The Myelin Repair Foundation (MRF) today has granted a non-exclusive sublicense to Biogen Idec (NASDAQ: BIIB) for the use of MRF's technologies to generate a novel mouse model for all demyelinating ...
SARATOGA, CALIFORNIA - January 20, 2004 - The Myelin Repair Foundation (MRF), a Saratoga, Calif.-based non-profit research foundation, today announced the formation of a consortium of five of the ...
A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug’s ...
SARATOGA, Calif. – May 20, 2012 –The Myelin Repair Foundation (MRF) today announced the results of a new peer-reviewed research study published in Nature Neuroscience that demonstrates functional ...
An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears ...
In the nearly 1 million Americans living with multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system—called myelin—is damaged. This slows the transmission of ...
In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells — one of the few brain cell types that continue to be produced in the adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results